{"entity":{"type":"insider","cik":"0001476301","url":"/insider/0001476301","json_url":"/insider/0001476301.json","name":"Anderson Katherine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2012-04-16","last":"2016-01-28","span_basis":"filed_date"},"name_variants":[{"name":"Anderson Katherine","source":"filing","n_filings":7,"first_seen":"2012-04-16","last_seen":"2016-01-28"}],"transactions":[{"id":2155861,"accession":"0001144204-16-077572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-077572","line_url":"/filing/0001144204-16-077572#line-1","is_derivative":false,"issuer_cik":"0000897075","issuer_name":"REPROS THERAPEUTICS INC.","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0000897075","owner_cik":"0001476301","owner_name":"Anderson Katherine","owner_url":"/insider/0001476301","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":12960.0,"total_display":"12,960.00","shares_owned_after":23875.0,"shares_owned_after_display":"23,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-27","filed_date":"2016-01-28","scope":"insider"},{"id":6693575,"accession":"0001144204-14-067297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-067297","line_url":"/filing/0001144204-14-067297#line-1","is_derivative":false,"issuer_cik":"0000897075","issuer_name":"REPROS THERAPEUTICS INC.","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0000897075","owner_cik":"0001476301","owner_name":"Anderson Katherine","owner_url":"/insider/0001476301","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":9.4148,"price_display":"9.41","price_state":"stated","total_value":32951.8,"total_display":"32,951.80","shares_owned_after":11875.0,"shares_owned_after_display":"11,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-12","scope":"insider"},{"id":6378713,"accession":"0001144204-14-050109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-050109","line_url":"/filing/0001144204-14-050109#line-1","is_derivative":false,"issuer_cik":"0000897075","issuer_name":"REPROS THERAPEUTICS INC.","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0000897075","owner_cik":"0001476301","owner_name":"Anderson Katherine","owner_url":"/insider/0001476301","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":13.85,"price_display":"13.85","price_state":"stated","total_value":27700.0,"total_display":"27,700.00","shares_owned_after":8375.0,"shares_owned_after_display":"8,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-14","filed_date":"2014-08-14","scope":"insider"},{"id":4257446,"accession":"0001476301-13-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001476301-13-000002","line_url":"/filing/0001476301-13-000002#line-1","is_derivative":false,"issuer_cik":"0000897075","issuer_name":"REPROS THERAPEUTICS INC.","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0000897075","owner_cik":"0001476301","owner_name":"Anderson Katherine","owner_url":"/insider/0001476301","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":17.9,"price_display":"17.90","price_state":"stated","total_value":17900.0,"total_display":"17,900.00","shares_owned_after":6375.0,"shares_owned_after_display":"6,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-25","filed_date":"2013-10-25","scope":"insider"},{"id":4275228,"accession":"0000897075-13-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897075-13-000001","line_url":"/filing/0000897075-13-000001#line-1","is_derivative":false,"issuer_cik":"0000897075","issuer_name":"REPROS THERAPEUTICS INC.","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0000897075","owner_cik":"0001476301","owner_name":"Anderson Katherine","owner_url":"/insider/0001476301","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":23.77,"price_display":"23.77","price_state":"stated","total_value":23770.0,"total_display":"23,770.00","shares_owned_after":5375.0,"shares_owned_after_display":"5,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-10","filed_date":"2013-10-11","scope":"insider"},{"id":4477485,"accession":"0001476301-13-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001476301-13-000001","line_url":"/filing/0001476301-13-000001#line-1","is_derivative":false,"issuer_cik":"0000897075","issuer_name":"REPROS THERAPEUTICS INC.","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0000897075","owner_cik":"0001476301","owner_name":"Anderson Katherine","owner_url":"/insider/0001476301","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.89,"price_display":"11.89","price_state":"stated","total_value":11890.0,"total_display":"11,890.00","shares_owned_after":4375.0,"shares_owned_after_display":"4,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-01","filed_date":"2013-02-04","scope":"insider"},{"id":3302872,"accession":"0001181431-12-024045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-024045","line_url":"/filing/0001181431-12-024045#line-1","is_derivative":false,"issuer_cik":"0000897075","issuer_name":"REPROS THERAPEUTICS INC.","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0000897075","owner_cik":"0001476301","owner_name":"Anderson Katherine","owner_url":"/insider/0001476301","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.855,"price_display":"3.86","price_state":"stated","total_value":11565.0,"total_display":"11,565.00","shares_owned_after":3375.0,"shares_owned_after_display":"3,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-13","filed_date":"2012-04-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000897075","name":"REPROS THERAPEUTICS INC.","url":"/issuer/0000897075","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2012-04-16","last_seen":"2016-01-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001476301","retrieved_at":"2026-08-21T21:21:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}